Craig A Beam, PhD

Liu Y.F., Powrie J., Arif S., Yang J.H.M., Williams E., Khatri L., Joshi M., Lhuillier L., Fountoulakis N., Smith E., Beam C., Lorenc A., Peakman M., Tree T. Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple b-Cell Peptides in Type 1 Diabetes Diabetes. 2022;71:722-732.

Beam C.A., Beli E., Wasserfall C.H., Woerner S.E., Legge M.T., Evans-Molina C., McGrail K.M., Silk R., Grant M.B., Atkinson M.A., DiMeglio L.A. Peripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetes Diabetologia. 2021;64:1822-1833.

Arif S., Gomez-Tourino I., Kamra Y., Pujol-Autonell I., Hanton E., Tree T., Melandri D., Hull C., Wherrett D.K., Beam C., Roep B.O., Lorenc A., Peakman M. GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells Diabetologia. 2020;63(6):1186-1198.

Beam C.A., Wasserfall C., Woodwyk A., Akers M.K., Rauch H., Blok T., Mason P., Vos D., Perry D., Brusko T., Peakman M., Atkinson M. Synchronization of the Normal Human Peripheral Immune System: A Comprehensive Circadian Systems Immunology Analysis Scientific Reports. 2020;10

Eichmann M., Baptista R., Ellis R.J., Heck S., Peakman M., Beam C.A. Costimulation blockade disrupts CD4⁺ T cell memory pathways and uncouples their link to decline in b-cell function in type 1 diabetes Journal of Immunology. 2020;204(12):3129-3138.

Hannelius U., Beam C.A., Ludvigsson J. Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes Diabetologia. 2020;63:2177-2181.

Ludvigsson J., Routray I., Elluru S., Leanderson P., Larsson H.E., Rathsman B., Hanås R., Carlsson A., Ek T., Samuelsson U., Torbjörnsdotter T., Åman J., Örtqvist E., Badwal K., Beam C., Casas R. Combined vitamin D, ibuprofen and glutamic acid decarboxylase-alum treatment in recent onset Type i diabetes: Lessons from the DIABGAD randomized pilot trial Future Science OA. 2020;6

Yeo L., Woodwyk A., Sood S., Lorenc A., Eichmann M., Pujol-Autonell I., Melchiotti R., Skowera A., Fidanis E., Dolton G.M., Tungatt K., Sewell A.K., Heck S., Saxena A., Beam C.A., Peakman M. Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes Journal of Clinical Investigation. 2018;128(8):3460-3474.

Ali M.A., Liu Y.F., Arif S., Tatovic D., Shariff H., Gibson V.B., Yusuf N., Baptista R., Eichmann M., Petrov N., Heck S., Yang J.H.M., Tree T.I.M., Irma P.A., Yeo L., Baumard L.R., Stenson R., Howell A., Clark A., Boult Z., Powrie J., Adams L., Wong F.S., Luzio S., Dunseath G., Green K., OKeefe A., Bayly G., Thorogood N., Andrews R., Leech N., Joseph F., Nair S., Seal S., Cheung H., Beam C., Hills R., Peakman M., Dayan C.M. Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes Science Translational Medicine. 2017;9(402)

Beam C.A., MacCallum C., Herold K.C., Wherrett D.K., Palmer J., Ludvigsson J. GAD vaccine reduces insulin loss in recently diagnosed type 1 diabetes: findings from a Bayesian meta-analysis Diabetologia. 2017;60(1):43-49.

Hao W., Wookwyk A., Beam C., Bahnson H.T., Palmer J.P., Greenbaum C.J. Assessment of β cell mass and function by airmax and intravenous glucose in high-risk subjects for type 1 diabetes Journal of Clinical Endocrinology and Metabolism. 2017;102(12):4428-4434.

Orban T., Beam C.A., Xu P., Moore K., Jiang Q., Deng J., Muller S., Gottlieb P., Spain L., Peakman M. Reduction in CD4 central memory T-cell subset in costimulation modulator abatacept-treated patients with recent-onset type 1 diabetes is associated with slower C-peptide decline Diabetes Technology and Therapeutics. 2016;18:S74-S75.

Beam C.A. Statistical considerations when analyzing biomarker data Clinical Immunology. 2015;161(1):31-36.

Bingley P.J., Rafkin L.E., Matheson D., Steck A.K., Yu L., Henderson C., Beam C.A., Boulware D.C. Use of dried capillary blood sampling for islet autoantibody screening in relatives: A feasibility study Diabetes Technology and Therapeutics. 2015;17(12):867-871.

Bollyky J.B., Xu P., Butte A.J., Wilson D.M., Beam C.A., Greenbaum C.J. Heterogeneity in recent-onset type 1 diabetes - a clinical trial perspective Diabetes/Metabolism Research and Reviews. 2015;31(6):588-594.

Herold K.C., Usmani-Brown S., Ghazi T., Lebastchi J., Beam C.A., Bellin M.D., Ledizet M., Sosenko J.M., Krischer J.P., Palmer J.P. β Cell death and dysfunction during type 1 diabetes development in at-risk individuals Journal of Clinical Investigation. 2015;125(3):1163-1173.

Sosenko J.M., Skyler J.S., Beam C.A., Boulware D., Mahon J.L., Krischer J.P., Greenbaum C.J., Rafkin L.E., Matheson D., Herold K.C., Palmer J.P. The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months Diabetes Care. 2015;38(5):940-942.

Sosenko J.M., Skyler J.S., Dimeglio L.A., Beam C.A., Krischer J.P., Greenbaum C.J., Boulware D., Rafkin L.E., Matheson D., Herold K.C., Mahon J., Palmer J.P. A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history Diabetes Care. 2015;38(2):271-276.

Beam C.A., Gitelman S.E., Palmer J.P. Recommendations for the definition of clinical responder in insulin preservation studies Diabetes. 2014;63(9):3120-3127.

Max Andersen M.L., Nielsen L.B., Svensson J., Pörksen S., Hougaard P., Beam C., Greenbaum C., Becker D., Petersen J.S., Hansen L., Mortensen H.B. Disease progression among 446 children with newly diagnosed type 1 diabetes located in Scandinavia, Europe, and North America during the last 27yr Pediatric Diabetes. 2014;15(5):345-354.

Orban T., Beam C.A., Xu P., Moore K., Jiang Q., Deng J., Muller S., Gottlieb P., Spain L., Peakman M. Reduction in CD4 central memory T-cell subset in costimulation modulator abatacept-treated patients with recent-onset type 1 diabetes is associated with slower C-peptide decline Diabetes. 2014;63(10):3449-3457.

Sosenko J.M., Skyler J.S., Mahon J., Krische J.P., Greenbaum C.J., Rafkin L.E., Beam C.A., Boulware D.C., Matheson D., Cuthbertson D., Herold K.C., Eisenbarth G., Palmer J.P. Use of the diabetes prevention trial-type 1 risk score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes Diabetes Care. 2014;37(4):979-984.

Usmani-Brown S., Lebastchi J., Steck A.K., Beam C., Herold K.C., Ledizet M. Analysis of β-cell death in type 1 diabetes by droplet digital PCR Endocrinology (United States). 2014;155(9):3694-3698.

Greenbaum C.J., Beam C.A. Response to comment on: Greenbaum et al. Fall in C-peptide during first 2 years from diagnosis: Evidence of at least two distinct phases from composite type 1 diabetes trialNet data. Diabetes 2012;61:2066-2073 Diabetes. 2013;62(6)

Greenbaum C.J., Beam C.A., Boulware D., Gitelman S.E., Gottlieb P.A., Herold K.C., Lachin J.M., McGee P., Palmer J.P., Pescovitz M.D., Krause-Steinrauf H., Skyler J.S., Sosenko J.M. Fall in C-peptide during first 2 years from diagnosis: Evidence of at least two distinct phases from composite type 1 diabetes TrialNet data Diabetes Technology and Therapeutics. 2013;15(SUPPL.1)

Kroll J.L., Beam C., Li S., Viscidi R., Dighero B., Cho A., Boulware D., Pescovitz M., Weinberg A. Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes Journal of Clinical Virology. 2013;57(2):115-119.

Sosenko J.M., Skyler J.S., Beam C.A., Krischer J.P., Greenbaum C.J., Mahon J., Rafkin L.E., Matheson D., Herold K.C., Palmer J.P. Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants Diabetes. 2013;62(12):4179-4183.

Sosenko J.M., Skyler J.S., Palmer J.P., Krischer J.P., Yu L., Mahon J., Beam C.A., Boulware D.C., Rafkin L., Schatz D., Eisenbarth G. The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients Diabetes Care. 2013;36(9):2615-2620.

Greenbaum C.J., Beam C.A., Boulware D., Gitelman S.E., Gottlieb P.A., Herold K.C., Lachin J.M., McGee P., Palmer J.P., Pescovitz M.D., Krause-Steinrauf H., Skyler J.S., Sosenko J.M. Fall in C-peptide during first 2 years from diagnosis: Evidence of at least two distinct phases from composite type 1 diabetes trialnet data Diabetes. 2012;61(8):2066-2073.

Pollard B.J., Samei E., Chawla A.S., Beam C., Heyneman L.E., Koweek L.M.H., Martinez-Jimenez S., Washington L., Hashimoto N., McAdams H.P. The effects of ambient lighting in chest radiology reading rooms Journal of Digital Imaging. 2012;25:520-526.

Sosenko J.M., Skyler J.S., Mahon J., Krischer J.P., Beam C.A., Boulware D.C., Greenbaum C.J., Rafkin L.E., Cowie C., Cuthbertson D., Palmer J.P. The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes Diabetes Care. 2012;35(7):1552-1555.

Vehik K., Rewers M.J., Cuthbertson D., Schatz D.A., Boulware D., Krischer J.P., Beam C.A., Rodriguez H., Legault L., Hyytinen M. Performance of HbA <inf>1c</inf> as an early diagnostic indicator of type 1 diabetes in children and youth Diabetes Care. 2012;35(9):1821-1825.

Xu P., Beam C.A., Cuthbertson D., Sosenko J.M., Skyler J.S., Krischer J.P. Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population receiver operating characteristic analysis Diabetes Care. 2012;35(10):1975-1980.

Yu L., Boulware D.C., Beam C.A., Hutton J.C., Wenzlau J.M., Greenbaum C.J., Bingley P.J., Krischer J.P., Sosenko J.M., Skyler J.S., Eisenbarth G.S., Mahon J.L. Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies Diabetes Care. 2012;35(6):1213-1218.

Coursey C.A., Nelson R.C., Moreno R.D., Patel M.B., Beam C.A., Vaslef S. Appendicitis, body mass index, and CT: Is CT more valuable for obese patients than thin patients? American Surgeon. 2011;77:471-475.

Mahon J.L., Beam C.A., Marcovina S.M., Boulware D.C., Palmer J.P., Winter W.E., Skyler J.S., Krischer J.P. Comparison of two insulin assays for first-phase insulin release in type 1 diabetes prediction and prevention studies Clinica Chimica Acta. 2011;412(23-24):2128-2131.

Sarafanov A.G., Todorov T.I., Centeno J.A., MacIas V., Gao W., Liang W.M., Beam C., Gray M.A., Kajdacsy-Balla A.A. Prostate cancer outcome and tissue levels of metal ions Prostate. 2011;71:1231-1238.

Sosenko J.M., Skyler J.S., Mahon J., Krischer J.P., Beam C.A., Boulware D.C., Greenbaum C.J., Rafkin L.E., Cowie C., Cuthbertson D., Palmer J.P. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study Diabetes Care. 2011;34(8):1785-1787.

Vehik K., Beam C.A., Mahon J.L., Schatz D.A., Haller M.J., Sosenko J.M., Skyler J.S., Krischer J.P. Development of autoantibodies in the TrialNet natural history study Diabetes Care. 2011;34(9):1897-1901.

Vehik K., Haller M.J., Beam C.A., Schatz D.A., Wherrett D.K., Sosenko J.M., Krischer J.P. Islet autoantibody seroconversion in the DPT-1 study: Justification for repeat screening throughout childhood Diabetes Care. 2011;34(2):358-362.

Asztalos S., Gann P.H., Hayes M.K., Nonn L., Beam C.A., Dai Y., Wiley E.L., Tonetti D.A. Gene expression patterns in the human breast after pregnancy Cancer Prevention Research. 2010;3(3):301-311.

Coursey C.A., Nelson R.C., Patel M.B., Cochran C., Dodd L.G., DeLong D.M., Beam C.A., Vaslef S. Making the diagnosis of acute appendicitis: Do more preoperative CT scans mean fewer negative appendectomies? A 10-year study Radiology. 2010;254:460-468.

Davidson M.H., Beam C.A., Haffner S., Perez A., Dagostino R., Mazzone T. Pioglitazone versus glimepiride on coronary artery calcium progression in patients with type 2 diabetes mellitus: A secondary end point of the CHICAGO study Arteriosclerosis, Thrombosis, and Vascular Biology. 2010;30(9):1873-1876.

Peterson C.E., Sedjo R.L., Davis F.G., Beam C.A., Giuliano A.R. Combined antioxidant carotenoids and the risk of persistent human papillomavirus infection Nutrition and Cancer. 2010;62(6):728-733.

Beam C.A., Gao W., Macias V., Liang W., Balla A.K. Sequential testing approach as an efficient and easier alternative for the validation of new predictive technologies in the clinic Journal of Clinical Oncology. 2009;27:1087-1090.

Coursey C.A., Hollingsworth C.L., Wriston C., Beam C., Rice H., Bisset G. Radiographic predictors of disease severity in neonates and infants with necrotizing enterocolitis American Journal of Roentgenology. 2009;193:1408-1413.

Heine J.J., Cao K., Beam C. Cumulative sum quality control for calibrated breast density measurements Medical Physics. 2009;36:5380-5390.

Schwartz J.L., Panda S., Beam C., Bach L.E., Adami G.R. RNA from brush oral cytology to measure squamous cell carcinoma gene expression Journal of Oral Pathology and Medicine. 2008;37:70-77.

Jaffe R.C., Ferguson-Gottschall S.D., Gao W., Beam C., Fazleabas A.T. Histone deacetylase inhibition and progesterone act synergistically to stimulate baboon glycodelin gene expression Journal of Molecular Endocrinology. 2007;38:401-407.

Lee J.H., Eschrich S., Beam C. An exact test for detecting inconsistency in readers interpretation over time in screening mammograms Biometrical Journal. 2007;49:672-681.

Waterman S.R., Hacham M., Hu G., Zhu X., Park Y.D., Shin S., Panepinto J., Valyi-Nagy T., Beam C., Husain S., Singh N., Williamson P.R. Role of a CUF1/CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans Journal of Clinical Investigation. 2007;117:794-802.

Araki H., Mahmud N., Milhem M., Nunez R., Xu M., Beam C.A., Hoffman R. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents Experimental Hematology. 2006;34:140-149.

Beam C.A., Conant E.F., Sickles E.A. Correlation of radiologist rank as a measure of skill in screening and diagnostic interpretation of mammograms Radiology. 2006;238:446-453.

Beam C.A., Krupinski E.A., Kundel H.L., Sickles E.A., Wagner R.F. The Place of Medical Image Perception in 21st-Century Health Care Journal of the American College of Radiology. 2006;3:409-412.

Diaz N., Minton S., Cox C., Bowman T., Gritsko T., Garcia R., Eweis I., Wloch M., Livingston S., Seijo E., Cantor A., Lee J.H., Beam C.A., Sullivan D., Jove R., Muro-Cacho C.A. Activation of Stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated Src and survivin expression Clinical Cancer Research. 2006;12:20-28.

Gritsko T., Williams A., Turkson J., Kaneko S., Bowman T., Huang M., Nam S., Eweis I., Diaz N., Sullivan D., Yoder S., Enkemann S., Eschrich S., Lee J.H., Beam C.A., Cheng J., Minton S., Muro-Cacho C.A., Jove R. Persistent activation of Stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells Clinical Cancer Research. 2006;12:11-19.

Hazlehurst L.A., Argilagos R.F., Emmons M., Boulware D., Beam C.A., Sullivan D.M., Dalton W.S. Cell adhesion to fibronectin (CAM-DR) influences acquired mitoxantrone resistance in U937 cells Cancer Research. 2006;66:2338-2345.

Arora R., Kundel H.L., Beam C.A. Perceptually based FROC analysis Academic Radiology. 2005;12:1567-1574.

Beam C.A., Conant E.F., Krupinski E.A., Kundel H.L., Sickles E.A. Interpreting the ROC curve from the radiologist's point of view: The "Diagnostician Operating Choice" (DOC) curve Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2005;5749:8-14.

Zhu K., Gerbino E., Beaupre D.M., Mackley P.A., Muro-Cacho C., Beam C., Hamilton A.D., Lichtenheld M.G., Kerr W.G., Dalton W., Alsina M., Sebti S.M. Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells Blood. 2005;105:4759-4766.

Beam C.A. Relative valuation of health outcomes expressed by the use of diagnostic technology in medicine Health Services and Outcomes Research Methodology. 2004;5:153-154.

Beam C.A., Conant E.F., Sickles E.A., Merritt C.B. Evaluation of proscriptive health care policy implementation in screening mammography Breast Diseases. 2004;15:154-155.

Wagner R.F., Beam C.A., Beiden S.V. Reader variability in mammography and its implications for expected utility over the population of readers and cases Medical Decision Making. 2004;24:561-572.

Beam C.A. Statistical constancy between binormal parameters in reader populations Proceedings of SPIE - The International Society for Optical Engineering. 2003;5034:225-229.

Beam C.A. Interpretion error in mammography: Taxonomy and measurement Seminars in Breast Disease. 2003;6:153-157.

Beam C.A., Conant E.F., Sickles E.A. Association of volume-independent factors with accuracy in screening mammogram interpretation Journal of the National Cancer Institute. 2003;95:282-290.

Beam C.A., Conant E.F., Sickles E.A., Weinstein S.P. Evaluation of Proscriptive Health Care Policy Implementation in Screening Mammography Radiology. 2003;229:534-540.

Hazlehurst L.A., Enkemann S.A., Beam C.A., Argilagos R.F., Painter J., Shain K.H., Saporta S., Boulware D., Moscinski L., Alsina M., Dalton W.S. Genotypic and Phenotypic Comparisons of de Novo and Acquired Melphalan Resistance in an Isogenic Multiple Myeloma Cell Line Model Cancer Research. 2003;63:7900-7906.

Wagner R.F., Beam C.A., Beiden S.V. A study of the propagation of reader variability in mammography to the variable expected benefit over the population Proceedings of SPIE - The International Society for Optical Engineering. 2003;5034:238-241.

Beam C.A. A two-stage ROC curve regression model when sampling a population of diagnosticians Proceedings of SPIE - The International Society for Optical Engineering. 2002;4686:236-247.

Beam C.A. Reader strategies: Variability and error-methodology, findings and health policy implications from a study of the US population of mammographers Proceedings of SPIE - The International Society for Optical Engineering. 2002;4686:157-168.

Beam C.A. Statistically engineering the study for success American Journal of Roentgenology. 2002;179:47-52.

Beam C.A., Conant E.F., Sickles E.A. Factors affecting radiologist inconsistency in screening mammography Academic Radiology. 2002;9:531-540.

Berg W.A., D'Orsi C.J., Jackson V.P., Bassett L.W., Beam C.A., Lewis R.S., Crewson P.E. Does training in the breast imaging reporting and data system (BI-RADS) improve biopsy recommendations or feature analysis agreement with experienced breast imagers at mammography? Radiology. 2002;224:871-880.

Beam C.A., Blackmore C.C., Karlik S., Reinhold C. Editors' introduction to the series American Journal of Roentgenology. 2001;176:323-325.

Brunken R.C., Neumann D.R., Bybel B., Blackmore C.C., Beam C.A. Beyond radiology consultant [3] American Journal of Roentgenology. 2001;177:1216-1217.

Navas-Nacher E.L., Colangelo L., Beam C., Greenland P. Risk factors for coronary heart disease in men 18 to 39 years of age Annals of Internal Medicine. 2001;134:433-439.

Bluth E.I., Sunshine J.H., Lyons J.B., Beam C.A., Troxclair L.A., Althans-Kopecky L., Crewson P.E., Sullivan M.A., Smetherman D.H., Heidenreich P.A., Neiman H.L., Burkhardt J.H. Power Doppler imaging: Initial evaluation as a screening examination for carotid artery stenosis Radiology. 2000;215:791-800.

Beam C.A. We cannot choose to ignore outcomes in the clinical assessment of diagnostic technologies. Academic radiology. 1999;6 Suppl 1

Beam C.A., Guse C.E., Sullivan D.C. A sequential chart for the audit-based evaluation of screening mammogram interpretation Academic Radiology. 1999;6:216-223.

Bossuyt P.M.M., Lijmer J.G., Beam C.A., Campbell G., Burken M.I., Greenfield S., Gatsonis C., Bree R.L., Mushlin A.I., Dorfman G.S., Hillman B., Schulman K., Jarvik J.G. Traditional health outcomes in the evaluation of diagnostic tests Academic Radiology. 1999;6

Hendee W.R., Beam C., Hendrick R.E. Proposition: All mammograms should be double-read Medical Physics. 1999;26:115-118.

Beam C.A. Analysis of clustered data in receiver operating characteristic studies Statistical Methods in Medical Research. 1998;7:324-336.

Beam C., Sullivan D. Variability in mammogram interpretation. Administrative radiology journal : AR. 1996;15

Beam C.A. Sampling Design Matters Medical Decision Making. 1996;16:197.

Beam C.A., Layde P.M., Sullivan D.C. Variability in the interpretation of screening mammograms by US radiologists: Findings from a national sample Archives of Internal Medicine. 1996;156:209-213.

Beam C.A., Sullivan D.C., Layde P.M. Effect of human variability on independent double reading in screening mammography. Academic radiology. 1996;3:891-897.

Black W.C., Beam C.A., Camaratta J., Hanley J., Malenka D., Sugarman M., Thornbury J.R., Wagner R.F. Report from efficacy subgroup MR methodology workshop Journal of Magnetic Resonance Imaging. 1996;6:1-3.

Sostman H.D., Beam C.A. Evaluation of the quality of clinical research studies of magnetic resonance angiography: 1991-1994 Journal of Magnetic Resonance Imaging. 1996;6:33-38.

Beam C.A. Random-effects models in the receiver operating characteristic curve-based assessment of the effectiveness of diagnostic imaging technology: concepts, approaches, and issues. Academic radiology. 1995;2 Suppl 1

Layde P.M., Beam C.A., Broste S.K., Connors A.F., Desbiens N., Lynn J., Phillips R.S., Reding D., Teno J., Vidaillet H., Wenger N. Surrogates’ Predictions of Seriously Ill Patients’ Resuscitation Preferences Archives of Family Medicine. 1995;4:518-523.

Beam C.A., Sullivan D.C. What are the issues in the double reading of mammograms? [1] Radiology. 1994;193:582.

Sukhatme S., Beam C.A. Stratification in nonparametric ROC studies Biometrics. 1994;50:149-163.

Baker M.E., Beam C., Leder R., Gulliver D., Paine S.S., Dunnick N.R. Contrast material for combined abdominal and pelvic CT: Can cost be reduced by increasing the concentration and decreasing the volume? American Journal of Roentgenology. 1993;160:637-641.

Evans A.J., Iwai F., Grist T.A., Sostman H.D., Hedlund L.W., Spritzer C.E., Negro-Vilar R., Beam C.A., Pelc N.J. Magnetic resonance imaging of blood flow with a phase subtraction technique: In vitro and in vivo validation Investigative Radiology. 1993;28:109-115.

Evans A.J., Sostman H.D., Knelson M.H., Spritzer C.E., Newman G.E., Paine S.S., Beam C.A. Detection of deep venous thrombosis: Prospective comparison of MR imaging with contrast venography American Journal of Roentgenology. 1993;161:131-139.

Janower M.L., Beam C., Baker M.E., Sostman H.D., Sullivan D. Proposal for a shared resource in clinical diagnostic radiology research [3] Radiology. 1993;186:581.

Radtke R.A., Hanson M.W., Hoffman J.M., Crain B.J., Walczak T.S., Lewis D.V., Beam C., Coleman R.E., Friedman A.H. Temporal lobe hypometabolism on PET: Predictor of seizure control after temporal lobectomy Neurology. 1993;43:1088-1092.

Schifter T., Hoffman J.M., Hanson M.W., Boyko O.B., Beam C., Paine S., Schold S.C., Burger P.C., Coleman R.E. Serial fdg-pet studies in the prediction of survival in patients with primary brain tumors Journal of Computer Assisted Tomography. 1993;17:509-516.

Beam C.A. Strategies for improving power in diagnostic radiology research American Journal of Roentgenology. 1992;159:631-637.

Beam C.A., Baker M.E., Paine S.S., Sostman H.D., Sullivan D.C. Answering unanswered questions: Proposal for a shared resource in clinical diagnostic radiology research Radiology. 1992;183:619-620.

Debatin J.F., Nadel S.N., Paolini J.F., Sostman H.D., Edward Coleman R., Evans A.J., Beam C., Spritzer C.E., Bashore T.M. Cardiac ejection fraction: Phantom study comparing cine MR imaging, radionuclide blood pool imaging, and ventriculography Journal of Magnetic Resonance Imaging. 1992;2:135-142.

Dobbins J.T., Rice J.J., Beam C.A., Ravin C.E. Threshold perception performance with computed and screen-film radiography: Implications for chest radiography Radiology. 1992;183:179-187.

Encarnacion C.E., Kadir S., Beam C.A., Payne C.S. Gastrointestinal bleeding: Treatment with gastrointestinal arterial embolization Radiology. 1992;183:505-508.

Frush D., Beam C., Effman E.L. Acute appendicitis in children: An evaluation with ultrasound Investigative Radiology. 1992;27:489-490.

Nemeroff C.B., Krishnan K.R.R., Reed D., Leder R., Beam C., Dunnick N.R. Adrenal Gland Enlargement in Major Depression: A Computed Tomographic Study Archives of General Psychiatry. 1992;49:384-387.

Beam C.A., Sostman H.D., Zheng J.Y. Status of clinical MR evaluations 1985 - 1988: Baseline and design for further assessments Radiology. 1991;180:265-270.

Beam C.A., Wieand S.H. A statistical method for the comparison of a discrete diagnostic test with several continuous diagnostic tests Biometrics. 1991;47:907-919.

Cohan R.H., Leder R.A., Herzberg A.J., Hedlund L.W., Wheeler C.T., Beam C.A., Nadel S.N., Dunnick N.R. Extravascular toxicity of two magnetic resonance contrast agents: Preliminary experience in the rat Investigative Radiology. 1991;26:224-226.

Debatin J.F., Spritzer C.E., Grist T.M., Beam C., Svetkey L.P., Newman G.E., Sostman H.D. Imaging of the renal arteries: Value of MR angiography American Journal of Roentgenology. 1991;157:981-990.

Hanson M.W., Feldman J.M., Beam C.A., Leight G.S., Coleman R.E. Iodine 131—Labeled Metaiodobenzylguanidine Scintigraphy and Biochemical Analyses in Suspected Pheochromocytoma Archives of Internal Medicine. 1991;151:1397-1402.

Iwai F., Sostman H.D., Evans A.J., Nadel S.N., Hedlund L.W., Beam C.A., Charles H.C., Spritzer C.E. Cine phase–contrast magnetic resonance imaging for analysis of flow phenomena in experimental aortic dissection Investigative Radiology. 1991;26:1071-1078.

Munechika H., Sullivan D.C., Hedlund L.W., Beam C.A., Sostman H.D., Herfkens R.J., Pelc N.J. Evaluation of acute renal failure with magnetic resonance imaging using gradient–echo and Gd–DTPA Investigative Radiology. 1991;26:22-27.

Sullivan D.C., Beam C.A., Goodman S.M., Watt D.L. Measurement of force applied during mammography Radiology. 1991;181:355-357.

White K.S., Muelenaer A.A., Beam C.A., Effmann E.L. Determination of functional residual capacity from digital radiographs of the normal neonatal chest: Studies in a rabbit model American Journal of Roentgenology. 1991;156:1209-1214.

Beam C., Reed Dunnick N. Evaluation of iopamidol and diatrizoate in excretory urography: A double-blind clinical study: Reviewers comments Investigative Radiology. 1990;25:1255-1256.

Sostman H.D., Charles H.C., Rockwell S., Leopold K., Beam C., Madwed D., Dewhirst M., Cofer G., Moore D., Burn R., Oleson J. Soft-tissue sarcomas: Detection of metabolic heterogeneity with P-31 MR spectroscopy Radiology. 1990;176:837-843.